Point72 Middle East FZE’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-7,800
Closed -$516K 819
2023
Q4
$516K Sell
7,800
-23,900
-75% -$1.5M 0.02% 814
2023
Q3
$1.99M Buy
31,700
+7,800
+33% +$486K 0.07% 352
2023
Q2
$1.35M Buy
23,900
+7,600
+47% +$422K 0.04% 495
2023
Q1
$944K Buy
16,300
+8,400
+106% +$567K 0.03% 519
2022
Q4
$572K Buy
+7,900
New +$566K 0.03% 684

Other funds holding MET

Point72 Middle East FZE's MET Position: Q4 2023 in Review

Point72 Middle East FZE sold out of MetLife (MET) in Q4 2023, closing a stake of 94,165 shares — an estimated $5.89M sold.

Point72 Middle East FZE first reported a position in MET in Q4 2022 and held it in 4 quarters. The position peaked at $12.6M in Q2 2023. 1,261 funds tracked by Wall St. Rank hold MET as of Q4 2023.

  • Point72 Middle East FZE reported no remaining MetLife position as of Q4 2023 after selling out during the quarter.
  • Point72 Middle East FZE sold 94,165 MetLife shares in Q4 2023, an estimated $5.89M.
  • Point72 Middle East FZE first reported a position in MetLife in Q4 2022 and held it in 4 quarters.
  • Point72 Middle East FZE's MetLife position peaked at $12.6M in Q2 2023.
  • 1,261 funds tracked by Wall St. Rank held MetLife as of Q4 2023.

Based on Point72 Middle East FZE's 13F filing for Q4 2023, filed 14 Feb 2024.